Alexander Cherkassky - Delivering Mass Cytometry Solutions

With a Massachusetts background, Alexander Cherkassky serves as vice president and general manager of Downsteam Chromatography bioprocessing Business Unit of Thermo Fisher Scientific Inc. Since 2018, at his current job or prior job at Standard Biotools Inc (formerly Fluidigm Inc) he has provided human health solutions that drive development and manufacturing of innovative medicines. Guiding downstream chromatography business business within Thermo Fisher, or mass cytometry and tissue imaging and flow cytometry business within Standard Biotools Inc, Alexander Cherkassky delivers life science tools for cutting edge drug development/discovery of biologics drugs manufacturing, including Cell and Gene Therapy.

Alexander Cherkassky has delivered comprehensive commercialization plans that have grown the franchise while collaborating with translational medicine and clinical research executives. Attending industry conferences, he succinctly communicates the value of his company’s product portfolio. One of its niche-defining offerings is genetic newborn screening, which promises to save babies' lives.

Previously serving as a platform director with Thermo Fisher Scientific in Massachusetts, Alexander Cherkassky oversaw portfolio lifecycle management for a business focused on sales of clinical and medical mass spectrometry devices. An exercise enthusiast, he enjoys playing soccer in his free time. He is a longstanding fan of the European Champions and English Premiership leagues, with Liverpool FC his favorite team.